Individual Olink® NPXTM projects are generally normalized using either plate control normalization or intensity normalization methods. Since NPX is a relative measurement, in the case when a study is separated into multiple projects, an additional normalization step is needed to allow the data to be comparable across projects. The following tutorial is designed to give you an overview of the Olink bridging procedure for combining data sets from Olink® Explore 3072, Olink® Explore HT, and Olink® Reveal products.
Bridging samples – Overlapping samples run on two or more projects that are used as references to enable normalization. These samples are selected as described in the Introduction to Bridging tutorial to ensure samples are of high quality and span the range of the data. In the case of data containing LOD, samples are also filtered for high detectability. Bridging samples are selected from the project that is run first to run with the second project.
Project – A set of plates that run at the same time and have been normalized together. If two projects are not randomized or are run at different times then additional normalization is required.
Project effect/correction – As NPX is a relative quantification, overall NPX values may shift across projects. This can result in separation of projects that are part of the same study which can be corrected for using normalization or accounted for within a statistical model.
Within-product bridging – Normalization of two or more projects run on the same Olink product using bridging samples.
Between-product bridging - Normalization of two or more projects from different Olink products (in this case, Olink Explore 3072 and Olink Explore HT) using bridging samples.
Reference data – The project data which is being normalized to is known as the reference data. In the case of between-product bridging, the reference project is the Explore HT NPX data or Reveal NPX data. The reference data set is not altered during bridging and the other data set is adjusted to the reference data set using the bridging samples.
The joint analysis of two or more NPX projects run on the same Olink product often requires a project correction step to remove technical variation. One such method of normalizing two projects is referred to as bridge sample reference normalization, bridge normalization, or simply bridging. For more information on within-product bridging, see the Introduction to Bridging tutorial. Bridging makes certain assumptions on the distributions of the assays, namely that we are measuring the same true biological range no matter the setting. If an assay displays different distributions between projects, then both bridging and downstream statistical analysis will be affected. Within a product, we assume the variance and shape of the distribution remains constant within assays.
In the case where a study consists of separate projects run on Olink Explore 3072 and either Olink Explore HT or Olink Reveal, an additional project correction step is required to allow data from these two products to be analyzed together, which is referred to as between-product bridging. Olink Explore 3072, Olink Explore HT, and Olink Reveal are all products that use PEA technology combined with next generation sequencing (NGS) to calculate NPX for thousands of proteins. However, assays may vary more between products than within a product, and fewer assumptions can be made regarding the similarity of assay distributions and variance between products.
Since many of the assays profiled in Olink Explore 3072 are also found on Olink Explore HT or Olink Reveal, bridging data across products enables increased power in studies consisting of data from multiple Olink products, rather than limiting these studies to meta-analysis. However, differences between products, such as the number of assays being measured and the reagents being used, can sometimes lead to signal in one product and noise in another product. Bridging signal to noise can have detrimental effects on downstream statistical analysis. This means that while some assays will be able to be bridged using the same method as in within-product bridging, others will require a different normalization method, and some will not be bridgeable at all. This normalization strategy combines median-centering (as is used in within-product bridging) and quantile smoothing to normalize assays across products based on the assumption that assays can be bridged provided they have signal in both products or noise in both products.
For product bridging between an Olink Explore 3072 project and an Olink Explore HT project or an Olink Reveal project, the NPX values from the Olink Explore 3072 project can be normalized and made comparable to those from Olink Explore HT or Olink Reveal. This process is one-directional, and normalizing Olink Explore HT or Olink Reveal NPX values to Olink Explore 3072 is not supported. For product bridging between an Olink Explore HT project and an Olink Reveal project, normalization is supported in both directions.
The product bridging normalization uses the assays that are overlapping between the two products. ~2900 assays overlap between Olink Explore HT and Olink Explore 3072, ~850 assays overlap between Olink Reveal and Olink Explore 3072, ~1000 assays overlap between Olink Explore HT and Olink Reveal.
Each overlapping assay undergoes a series of checks that evaluate the number of counts, correlation, and difference of NPX ranges between the two data sets. If an assay has enough counts and comparable metrics between the two data sets, it is determined to be suitable for bridging (referred to as a “bridgeable assay”). Assays that are not suitable for bridging can either be excluded from downstream analysis in one or both products or results can be integrated across products using meta-analysis. The set of bridgeable assays across products will vary from data set to data set, based on the samples present within the studies. Depending on the NPX distribution of each bridgeable assay in the two data sets, the assay is normalized using either median normalization or quantile smoothing.
Bridging an Explore 3072 data set to an Explore HT NPX data set requires 40-64 bridging samples, bridging an Olink Explore 3072 data set to an Olink Reveal data set requires 32-48 bridging samples, while the bridging between Olink Explore HT data set and Olink Reveal data set requires 24-40 bridging samples. Bridging samples are shared samples among data sets and, as such, are analyzed in both data sets. Olink NPX data sets without shared samples cannot be combined using the bridging approach described below. More information on bridge sample selection can be found in the section selecting bridging samples of the Introduction to Bridging tutorial.
Prior to running a study with Explore HT or Olink Reveal, bridging
samples must be selected from the study run with Explore 3072 and be run
on the subsequent study. These samples can be selected using the
olink_bridgeselector() function in Olink Analyze as
detailed in the section selecting
bridging samples of the Introduction to Bridging tutorial.
In addition, for studies involving Explore HT and Reveal, bridging can also be performed directly between Explore HT and Reveal in either direction. In these cases, bridging samples should be selected from the run used as the reference and included in the corresponding subsequent run. The recommended number of bridge samples for within- and between- product bridging is summarized in the table below. When selecting bridge samples, the aim is to select samples that represent the dynamic range of the assay expression in the product. As such, quality control of the sample and, if available, proportion of data above LOD in the sample are considered when determining if a sample is chosen as a bridging sample. When LOD data is not available in the data export from Olink NPX software, LOD can optionally be calculated from fixed LOD or negative controls as detailed in the Calculating LOD from Olink Explore data tutorial.
| Olink Product | Number of Bridge Samples |
|---|---|
| ‘Olink Explore 3072’ to ‘Olink Explore HT’ | 40-64 |
| ‘Olink Explore 3072’ to ‘Olink Reveal’ | 32-48 |
| ‘Olink Explore HT’ to ‘Olink Reveal’ | 24-40 |
| ‘Olink Reveal’ to ‘Olink Explore HT’ | 24-40 |
Olink Explore 3072 to Olink Explore HT bridging requires Explore 3072 data and Explore HT data which have at least 40 to 64 bridge samples. Olink Explore 3072 to Olink Reveal bridging requires Explore 3072 data and Reveal data which have at least 32 to 48 bridge samples. Bridging between Olink Explore HT and Olink Reveal, requires Explore HT data and Reveal data which have at least 24 to 40 bridge samples.
For studies that include multiple Explore 3072 data sets, these data sets should first be bridged using a within-product approach, as described in the Introduction to bridging tutorial. The same principle applies when bridging data between Explore HT and Olink Reveal. If multiple HT or Reveal studies are available, it is recommended to first perform within-product bridging to combine all HT studies or all Reveal studies, respectively, before proceeding with between-product bridging.
The assays from Explore 3072 are matched to their corresponding assays in Explore HT or Reveal and evaluated to determine whether each assay is bridgeable. For studies involving Explore HT and Olink Reveal, the assays between these two products are also matched and assessed for bridgeability in the same manner. All assays are then normalized using both quantile smoothing and normalization based on the median of paired differences. The output is an adjusted data set that includes five additional columns, three of which relate specifically to bridging normalization:
BridgingRecommendation: a flag which indicates if
the assay is bridgeable and, if so, which normalization method is
recommended. One of the three values will be listed in this column:
“NotBridgeable”, “MedianCentering”, or “QuantileSmoothing”.
MedianCenteredNPX: NPX values after normalization
using the median of paired differences.
QSNormalizedNPX: NPX values after normalization
using quantile smoothing.
After bridging, data from Explore 3072 and the reference product (Explore HT or Reveal) are exported into a single data set. For studies involving both Explore HT and Olink Reveal, data are exported in the same way. Two additional columns are added to facilitate data mapping and export.
Project: the name of the project as defined in the
function input arguments df1_project_nr and
df2_project_nr.
OlinkID_PRODUCT: mapped Olink IDs from non-reference
Olink product. The term “PRODUCT” in the column name will be replaced by
the non-reference name of the product: “E3072”, “HT” or “Reveal”
(e.g. OlinkID_E3072). Olink IDs from the reference product
will be listed in the OlinkID column.
Note that regardless of the bridging recommendation, NPX values will be available for both normalization methods. A visual representation of the between-product bridging workflow is shown below.
Schematic of Between-Product Bridging Workflow
To normalize Explore 3072 data to Explore HT or Olink Reveal data,
the data sets should first be read into R using read_NPX().
If more than two datasets are being normalized, all Explore 3072 studies
should first be normalized through within-product bridging. The
resulting data set should then be used as input for between-product
bridging. In the case of multiple Explore HT studies or multiple Reveal
studies, only one study should be chosen as the reference data set.
The same principle applies to studies involving Explore HT and Olink
Reveal. When performing bridging between these products, data sets
should be read using read_NPX(). If multiple HT or Reveal
studies are available, within-product bridging should be performed
first, and the resulting data set should be used as the input.
The data can be loaded using read_NPX() function with
default Olink Software NPX file as input, as shown below.
### Use provided example dataset
# Explore 3072: CSV or parquet file
data_e3072 <- OlinkAnalyze::read_NPX(
filename = "~/NPX_Explore3072_location.parquet"
)
# Explore HT: parquet file
data_eht <- OlinkAnalyze::read_NPX(
filename = "~/NPX_ExploreHT_location.parquet"
)
# Reveal: CSV or parquet file
data_reveal <- OlinkAnalyze::read_NPX(
filename = "~/NPX_Reveal_location.parquet"
)The imported data should be further processed using the
check_npx() and clean_npx() functions to
ensure that the data is in the correct format for bridging and to
generate check logs to identify any potential issues with the data.
### NPX file preprocessing
# Generate check log
check_log_data_e3072 <- OlinkAnalyze::check_npx(
df = data_e3072
)
check_log_data_eht <- OlinkAnalyze::check_npx(
df = data_eht
)
check_log_data_reveal <- OlinkAnalyze::check_npx(
df = data_reveal
)
# Clean NPX data
data_e3072_clean <- OlinkAnalyze::clean_npx(
df = data_e3072,
check_log = check_log_data_e3072,
# keep internal and external controls
remove_control_sample = FALSE,
remove_control_assay = FALSE,
# keep datapoints with samples and assays warnings
remove_qc_warning = FALSE,
remove_assay_warning = FALSE
)
data_eht_clean <- OlinkAnalyze::clean_npx(
df = data_eht,
check_log = check_log_data_eht,
# keep internal and external controls
remove_control_sample = FALSE,
remove_control_assay = FALSE,
# keep datapoints with samples and assays warnings
remove_qc_warning = FALSE,
remove_assay_warning = FALSE
)
data_reveal_clean <- OlinkAnalyze::clean_npx(
df = data_reveal,
check_log = check_log_data_reveal,
# keep internal and external controls
remove_control_sample = FALSE,
remove_control_assay = FALSE,
# keep datapoints with samples and assays warnings
remove_qc_warning = FALSE,
remove_assay_warning = FALSE
)
# Generate check log on cleaned data
check_log_data_e3072_clean <- OlinkAnalyze::check_npx(
df = data_e3072_clean
)
check_log_data_eht_clean <- OlinkAnalyze::check_npx(
df = data_eht_clean
)
check_log_data_reveal_clean <- OlinkAnalyze::check_npx(
df = data_reveal_clean
)
# clean up environment
rm(
data_e3072,
data_eht,
data_reveal,
check_log_data_e3072,
check_log_data_eht,
check_log_data_reveal
)First, confirm that there are overlapping sample IDs within the study. Note that external controls should not be included in the list of bridging samples, as detailed in the section selecting bridging samples of the Introduction to Bridging tutorial. External control samples often share the same naming convention across data sets but may represent different samples due to reagent batch differences. Appending the project name to the end of the control samples can ensure unique Sample IDs. For the example below, Explore HT data is used as the reference project; however, the same process can be performed using Reveal as the reference data set. The equivalent workflow also applies when performing bridging between Explore HT and Reveal, where either product may be used as the reference.
# Note that if `SampleType` is not is input data:
# stringr::str_detect can be used to exclude control samples based on SampleID.
data_e3072_samples <- data_e3072_clean |>
dplyr::filter(
.data[["SampleType"]] == "SAMPLE"
) |>
dplyr::distinct(
.data[["SampleID"]]
) |>
dplyr::pull()
data_eht_samples <- data_eht_clean |>
dplyr::filter(
.data[["SampleType"]] == "SAMPLE"
) |>
dplyr::distinct(
.data[["SampleID"]]
) |>
dplyr::pull()
overlapping_samples <- dplyr::intersect(
x = data_e3072_samples,
y = data_eht_samples
) |>
unique()| Sample_A | Sample_N | Sample_AA | Sample_AN |
| Sample_B | Sample_O | Sample_AB | Sample_AO |
| Sample_C | Sample_P | Sample_AC | Sample_AP |
| Sample_D | Sample_Q | Sample_AD | Sample_AQ |
| Sample_E | Sample_R | Sample_AE | Sample_AR |
| Sample_F | Sample_S | Sample_AF | Sample_AS |
| Sample_G | Sample_T | Sample_AG | Sample_AT |
| Sample_H | Sample_U | Sample_AH | Sample_AU |
| Sample_I | Sample_V | Sample_AI | Sample_AV |
| Sample_J | Sample_W | Sample_AJ | Sample_AW |
| Sample_K | Sample_X | Sample_AK | Sample_AX |
| Sample_L | Sample_Y | Sample_AL | Sample_AY |
| Sample_M | Sample_Z | Sample_AM | Sample_AZ |
PCA plots for each dataset can be used to assess if any bridge samples are outliers in the dataset.
#### Extract bridging samples
data_e3072_before_br <- data_e3072_clean |>
dplyr::filter(
.data[["SampleType"]] == "SAMPLE"
) |>
# Note that if column `SampleType` is not in input data, the function
# stringr::str_detect can be used to exclude control samples based on naming
# convention.
dplyr::mutate(
Type = dplyr::if_else(
.data[["SampleID"]] %in% .env[["overlapping_samples"]],
paste0("Explore 3072 Bridge"),
paste0("Explore 3072 Sample")
)
)
data_eht_before_br <- data_eht_clean |>
dplyr::filter(
.data[["SampleType"]] == "SAMPLE"
) |>
# Note that if column `SampleType` is not in input data, the function
# stringr::str_detect can be used to exclude control samples based on naming
# convention.
dplyr::mutate(
Type = dplyr::if_else(
.data[["SampleID"]] %in% .env[["overlapping_samples"]],
paste0("Explore HT Bridge"),
paste0("Explore HT Sample")
)
)
### PCA plot
pca_e3072 <- OlinkAnalyze::olink_pca_plot(
df = data_e3072_before_br,
check_log = check_log_data_e3072_clean,
color_g = "Type",
quiet = TRUE
)
pca_eht <- OlinkAnalyze::olink_pca_plot(
df = data_eht_before_br,
check_log = check_log_data_eht_clean,
color_g = "Type",
quiet = TRUE
)
PCA plot prior to bridging for Explore 3072 data and data from the reference product. Bridge samples are indicated by color. PCA plots can be helpful in assessing if any bridge samples were outliers in one of the platforms.
The olink_normalization() functionality has been
expanded and can be used to determine which assays are bridgeable and of
the bridgeable assays what normalization method is advised, and to
calculate normalized NPX values for the non-reference project.
Normalized NPX values are calculated for all assays across products as
described in the Workflow Overview and
in the sections below. Within this function, the bridging
recommendations for each assay are determined and the NPX values are
normalized using the two methods described below.
The olink_normalization() function contains a
format argument that is set to FALSE by
default. This will export the data frame with the format shown in Table
4 of the Function Output section. The
values in the NPX column will remain unchanged and median-centered NPX
values and QS-normalized NPX values will be populated in the
MedianCenteredNPX and QSNormalizedNPX columns
for all datapoints, regardless of bridging recommendation.
If the format argument is set to TRUE, this will export
the data frame with the NPX values replaced with the bridged NPX values
corresponding to the bridging recommendation (see Table 5 of the Function Output section). For more
information, see the Downstream
Analysis section below.
### Perform bridge normalization
# Note:
# Project name is assigned by `df1_project_nr` and `df2_project_nr` parameters
# in `olink_normalization` function
# Perform between-product bridging without formatting for downstream analysis
npx_br_data <- OlinkAnalyze::olink_normalization(
df1 = data_eht_clean,
df2 = data_e3072_clean,
overlapping_samples_df1 = overlapping_samples,
df1_project_nr = "Explore HT",
df2_project_nr = "Explore 3072",
reference_project = "Explore HT",
format = FALSE,
df1_check_log = check_log_data_eht_clean,
df2_check_log = check_log_data_e3072_clean
)
# Perform between-product bridging with formatting for downstream analysis
npx_br_data <- OlinkAnalyze::olink_normalization(
df1 = data_eht_clean,
df2 = data_e3072_clean,
overlapping_samples_df1 = overlapping_samples,
df1_project_nr = "Explore HT",
df2_project_nr = "Explore 3072",
reference_project = "Explore HT",
format = TRUE,
df1_check_log = check_log_data_eht_clean,
df2_check_log = check_log_data_e3072_clean
)Use check_npx() and clean_npx() to ensure
that the data is in the correct format and to clean the data after
bridging.
# Generate check log
check_log_br_data <- OlinkAnalyze::check_npx(
df = npx_br_data
)
# Clean NPX data
npx_br_data_clean <- OlinkAnalyze::clean_npx(
df = npx_br_data,
check_log = check_log_br_data,
# keep only control samples as we will need them for downstream QC
remove_control_sample = FALSE
)
# Generate check log on cleaned data
check_log_br_data_clean <- OlinkAnalyze::check_npx(
df = npx_br_data_clean
)
# clean up environment
rm(
npx_br_data,
check_log_br_data
)For an assay to be bridgeable across products, it must either have signal in both products or be primarily background signal in both products. Bridging noise into signal or signal into noise can negatively impact downstream statistical analysis. To determine if an assay is bridgeable, the bridge samples from both products are used to assess the following criteria:
For assays that are bridgeable, the shape of the NPX distribution is compared between the two products:
An overview of these criteria is visualized below.
Criteria to determine the bridging recommendation for an assay. The assessment of linearity ensures bridging between signal in both platforms or noise in both platforms (but not between signal and noise). Similar NPX ranges and sufficient counts provide additional insight into an assay’s bridgeability. Distribution shape is assessed to determine recommended bridging method.
The olink_bridgeability_plot function generates a series
of figures on a per-assay basis for a data set generated from
between-product bridging, based on the bridging samples used in the
bridge normalization. The coloration of the figure headers indicate
whether that assay has been defined as bridgeable or not bridgeable. Red
headers indicate that an assay is not bridgeable and blue headers
indicate that an assay is bridgeable. The correlation plot, violin plot,
and bar chart figures illustrate the three criteria described above for
determining whether an assay is bridgeable.
If an assay is determined to be bridgeable, the ECDF curve and corresponding KS statistic are used to determine which normalization approach (median centering or quantile smoothing) is most suitable for between-product normalization.
Prior to assessment, outlier bridging samples are excluded. A sample is considered an outlier if the NPX value is more than 3 times the interquartile range above or below the median on either product.
After assessment, an assay is considered bridgeable if it meets any of the first three criteria. The fourth criterion determines which normalization method is recommended for bridging. Note that bridgeable assays will differ between projects based on the expression of bridge samples in the studies. Here, the Explore 3072 to Explore HT bridging case is shown as the example, although the same principles apply to other product combinations, including Olink Explore HT and Olink Reveal.
### Generate olink_bridgeability_plot figures
npx_br_data_bridgeable_plt <- npx_br_data_clean |>
dplyr::filter(
.data[["SampleType"]] == "SAMPLE"
) |>
OlinkAnalyze::olink_bridgeability_plot(
check_log = check_log_br_data_clean,
# Important to note that setting `olink_id` to NULL will generate plots for
# all assays. This can be computationally intensive if there are many
# assays!
# To generate plots for a subset of assays, set `olink_id` to a vector of
# Olink IDs of interest.
olink_id = NULL,
median_counts_threshold = 150L,
min_count = 10L
)
npx_br_data_bridgeable_plt[[1L]]
Visualization of an assay’s bridgeability criteria as generated by the
olink_bridgeability_plot() function.
If it is expected that both the kind of distribution and the variance per test between runs are the same, then normalization using the median of paired differences will be preferred. Normalization using the median of paired differences based on the bridging samples is performed in the following steps:
For each assay in the non-reference project (e.g. Explore 3072), the pairwise difference is calculated for each of the bridging samples with the Explore HT project.
The normalization factor is estimated for each assay by finding the median of the pairwise differences.
The assay-specific normalization factor for each assay is used to normalize each data point from the non-reference to the reference project.
Since Olink NGS products are distinct with different workflows involved in generating NPX data, some assays exist in corresponding but distinct NPX spaces. For those assays, the median of paired differences is insufficient for bridging because it uses only a single anchor point (the median/50% quantile). Instead, quantile smoothing (QS) using multiple anchor points (5%, 10%, 25%, 50%, 75%, 90%, and 95% quantiles) is preferred to map data from the non-reference set to the distribution of the reference set.
The normalization using QS uses bridging samples to perform the following steps:
Each data point of the samples from the non-reference project is mapped to the equivalent space in the reference product using an empirical cumulative distribution function. The empirical cumulative distribution function is a probability model that uses the observed NPX values of the bridging samples for an assay to create a step function that interpolates linearly between available data points.
The empirical distribution function is then used to map the data points from the source product to the reference product space using the specified quantiles. At this stage, all data points from the bridging samples have NPX values normalized to the reference product.
To normalize the remaining data, a spline regression model is constructed using the sorted data from the source product (prior to mapping) and the mapped values, along with the anchor points of the spline. A spline regression model divides the dataset at the quantiles and uses these quantiles as anchor points or knots; the model then fits the values between each anchor point.
The spline regression model is used to predict all remaining data points from the non-reference product into the space of the reference product. The model consists of piecewise linear regressions within the quantile intervals. The NPX value from the source product is used as the x-value in the appropriate interval to produce the predicted y-value corresponding to the NPX scale of the reference product.
The output from olink_normalization() function when used
for between product bridging is a data frame with concatenated data from
the two products and additional columns including adjusted NPX values,
bridging recommendations, mapping information, and project names. The
adjusted NPX values are notated in the columns
MedianCenteredNPX and QSNormalizedNPX. For
each assay a recommendation is listed in the
BridgingRecommendation column and lists what method, if
any, should be used for that assay. Additional columns including
OlinkID and OlinkID_PRODUCT Workflow Overview map the assays across
products and the Project column lists the name of the
project based on the df1_project_nr and
df2_project_nr arguments. As the reference data is not
altered during normalization, the normalized NPX values
(MedianCenteredNPX and QSNormalizedNPX) in the
reference data will be the same as the values in the NPX column which
contains the non-normalized data.
| SampleID | OlinkID | SampleType | WellID | PlateID | UniProt | Assay | AssayType | Panel | Block | NPX | PCNormalizedNPX | Count | Normalization | AssayQC | SampleQC | DataAnalysisRefID | Project | OlinkID_E3072 | MedianCenteredNPX | QSNormalizedNPX | BridgingRecommendation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample_A | OID40770 | SAMPLE | A1 | Plate1 | P08319 | ADH4 | assay | Cardiometabolic | A | 2.5 | 2.5 | 237 | Plate control | PASS | PASS | DAR001 | Explore 3072 | OID20117 | 0.8 | 1.3 | QuantileSmoothing |
| Sample_A | OID40835 | SAMPLE | A1 | Plate1 | P18848 | ATF4 | assay | Oncology_II | A | 1.0 | 1.0 | 186 | Plate control | PASS | PASS | DAR002 | Explore 3072 | OID31162 | 2.1 | 0.9 | MedianCentering |
| Sample_A | OID40981 | SAMPLE | A1 | Plate1 | O76039 | CDKL5 | assay | Neurology_II | A | 2.2 | 2.2 | 122 | Plate control | PASS | PASS | DAR003 | Explore 3072 | OID30796 | 0.6 | 0.9 | QuantileSmoothing |
| Sample_A | OID40986 | SAMPLE | A1 | Plate1 | P17676 | CEBPB | assay | Cardiometabolic | A | 1.1 | 1.1 | 419 | Plate control | PASS | PASS | DAR001 | Explore 3072 | OID20052 | 0.1 | 0.1 | QuantileSmoothing |
| Sample_A | OID41012 | SAMPLE | A1 | Plate1 | O96017 | CHEK2 | assay | Cardiometabolic | A | -2.0 | -0.7 | 423 | Plate control | PASS | PASS | DAR001 | Explore 3072 | OID20054 | -2.7 | -0.4 | NotBridgeable |
| SampleID | OlinkID | SampleType | WellID | PlateID | UniProt | Assay | AssayType | Panel | Block | NPX | PCNormalizedNPX | Count | Normalization | AssayQC | SampleQC | DataAnalysisRefID | Project | BridgingRecommendation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample_A_Explore 3072 | OID40770_OID20117 | SAMPLE | A1 | Plate1 | P08319 | ADH4 | assay | Cardiometabolic | A | 1.3 | 2.5 | 237 | Plate control | PASS | PASS | DAR001 | Explore 3072 | QuantileSmoothing |
| Sample_A_Explore 3072 | OID40835_OID31162 | SAMPLE | A1 | Plate1 | P18848 | ATF4 | assay | Oncology_II | A | 2.1 | 1.0 | 186 | Plate control | PASS | PASS | DAR002 | Explore 3072 | MedianCentering |
| Sample_A_Explore 3072 | OID40981_OID30796 | SAMPLE | A1 | Plate1 | O76039 | CDKL5 | assay | Neurology_II | A | 0.9 | 2.2 | 122 | Plate control | PASS | PASS | DAR003 | Explore 3072 | QuantileSmoothing |
| Sample_A_Explore 3072 | OID40986_OID20052 | SAMPLE | A1 | Plate1 | P17676 | CEBPB | assay | Cardiometabolic | A | 0.1 | 1.1 | 419 | Plate control | PASS | PASS | DAR001 | Explore 3072 | QuantileSmoothing |
| Sample_A_Explore 3072 | OID20054 | SAMPLE | A1 | Plate1 | O96017 | CHEK2 | assay | Cardiometabolic | A | -2.0 | -0.7 | 423 | Plate control | PASS | PASS | DAR001 | Explore 3072 | NotBridgeable |
PCA is used to assess the quality of bridging by determining if the sample controls (SCs) and bridging samples appear closer after bridging. Two PCAs can be generated, one containing the SCs and one containing the bridging samples. Prior to bridging there will be a noticeable separation between products which should decrease after bridging.
# Prepare data for PCA plots - pre-bridging
npx_pre_data <- data_eht_clean |>
dplyr::mutate(
Project = "Explore HT"
) |>
dplyr::bind_rows(
data_e3072_clean |>
dplyr::mutate(
Project = "Explore 3072"
)
)
check_log_pre_data <- OlinkAnalyze::check_npx(
df = npx_pre_data
)
# no need to clean data set `npx_pre_data`
# ```# Generate pre-bridging PCA using Sample Control samples
npx_pre_data |>
dplyr::filter(.data[["SampleType"]] == "SAMPLE_CONTROL") |>
dplyr::mutate(
SampleID = paste(.data[["Project"]], .data[["SampleID"]], sep = "_")
) |>
OlinkAnalyze::olink_pca_plot(
check_log = check_log_pre_data,
color_g = "Project",
)
Combined PCA of sample controls from both platforms prior to normalization.
# Generate pre-bridging PCA using bridging sample
npx_pre_data |>
dplyr::filter(
.data[["SampleType"]] == "SAMPLE"
) |>
dplyr::filter(
.data[["SampleID"]] %in% .env[["overlapping_samples"]]
) |>
dplyr::mutate(
SampleID = paste(.data[["Project"]], .data[["SampleID"]], sep = "_")
) |>
OlinkAnalyze::olink_pca_plot(
check_log = check_log_pre_data,
color_g = "Project"
)
Combined PCA of bridging samples from both platforms prior to normalization.
### Format post-bridging data
## Keep the data following BridgingRecommendation
npx_post_br_reco <- npx_br_data_clean |>
# Not necessary if olink_normalization() is run with format = TRUE
dplyr::filter(
.data[["BridgingRecommendation"]] != "NotBridgeable"
) |>
dplyr::mutate(
NPX = dplyr::case_when(
.data[["BridgingRecommendation"]] == "MedianCentering" ~
.data[["MedianCenteredNPX"]],
.data[["BridgingRecommendation"]] == "QuantileSmoothing" ~
.data[["QSNormalizedNPX"]],
.default = .data[["NPX"]]
)
)# Generate PCA plot of post-bridging data from Sample Controls
npx_post_br_reco |>
dplyr::filter(
.data[["SampleType"]] == "SAMPLE_CONTROL"
) |>
dplyr::mutate(
SampleID = paste(.data[["Project"]], .data[["SampleID"]], sep = "_")
) |>
OlinkAnalyze::olink_pca_plot(
color_g = "Project",
check_log = check_log_br_data_clean
)
Combined PCA of sample controls from both platforms after normalization.
# Generate PCA plot of post-bridging data from bridging samples
npx_post_br_reco |>
dplyr::filter(
.data[["SampleType"]] == "SAMPLE"
) |>
dplyr::filter(
.data[["SampleID"]] %in% .env[["overlapping_samples"]]
) |>
dplyr::mutate(
SampleID = paste0(.data[["Project"]], .data[["SampleID"]])
) |>
OlinkAnalyze::olink_pca_plot(
color_g = "Project",
check_log = check_log_br_data_clean
)
Combined PCA of bridging samples from both platforms after normalization.
The normalized non-reference data set (e.g. Explore 3072) can be
exported using arrow::write_parquet() to create a long
format Olink NGS file.
### Export normalized data
# Here we will export the full dataset including internal and external controls
# to follow Olink Software Export File formatting, but the data can be filtered
# to include only samples and assays of interest prior to export.
df <- npx_br_data |>
dplyr::filter(
.data[["Project"]] == "Explore_3072"
) |>
arrow::as_arrow_table()
df$metadata$FileVersion <- "NA"
df$metadata$ExploreVersion <- "NA"
df$metadata$ProjectName <- "NA"
df$metadata$SampleMatrix <- "NA"
df$metadata$DataFileType <- "R Package Export File"
df$metadata$ProductType <- "Explore3072"
df$metadata$Product <- "Explore3072"
arrow::write_parquet(
x = df,
sink = "path_to_output.parquet"
)Both the Explore 3072 and Explore HT products contain assays that appear multiple times in the product, known as overlapping assays or correlation assays. In Explore 3072, these present as overlapping assays across panels. In Explore HT, these are overlapping assays across blocks. These assays are included for QC purposes and allow users to evaluate data performance across panels in Explore 3072 and across blocks in Explore HT. Within each product, the assays contain unique OlinkID values for each of their corresponding panels and blocks in Explore 3072 and Explore HT, respectively.
IL6, IL8 (CXCL8), and TNF are included in the Cardiometabolic, Oncology, Neurology and Inflammation panels, while IDO1, LMOD1, and SCRIB are included in the Cardiometabolic II, Oncology II, Neurology II and Inflammation II panels. Each correlation assay is measured four times in an Olink Explore 3072 run. In Explore HT, GBP1 and MAPK1 serve as overlapping assays and are measured three times in a run.
Olink Analyze statistical analysis functions default to use the data
in the NPX column. To use the recommended normalized data,
set the olink_normalization() format argument to
TRUE when performing bridge normalization. The
NPX column values will be replaced with the recommended
normalized values corresponding to the normalization approach identified
in the BridgingRecommendation column. Datapoints identified
as NotBridgeable will retain their original NPX values and
OlinkIDs. Assays that are not overlapping between products will be
identified as “NotOverlapping” and will retain their original NPX values
and OlinkIDs. External controls will be removed from the formatted
dataframe. Sample IDs will be concatenated with their corresponding
project IDs to ensure that all samples are analyzed individually.
Additionally, to ensure that overlapping assays within products are
analyzed individually, OlinkID can be temporarily assigned to the
concatenated version of the OlinkIDs in the bridgeable assays. The
OlinkID_PRODUCT, MedianCenteredNPX, and
QSNormalizedNPX columns will be removed. This dataframe can
then be used in any downstream analysis function within Olink
Analyze.
Alternatively, if the olink_normalization() function is
run with the format argument set to ‘FALSE’, then the NPX
column will not be modified and the non-normalized NPX data will be used
by default. To use the recommended normalized data,
dplyr::mutate() can be used to reassign the NPX data.
Additionally, to ensure that overlapping assays within products are
analyzed individually, OlinkID can be temporarily assigned
to the concatenated version of the OlinkIDs. This dataframe can then be
used in any downstream analysis function within Olink Analyze.
Assays which are not recommended for bridging should be analyzed separately and can be combined using a meta-analysis. Depending on the study design these assays can either be excluded from the downstream analysis or the assays can be treated as non-overlapping assays.
### npx_post_br_clean generated by olink_normalization with format = TRUE
## Option 1: Exclude non-bridgeable assays from both products
npx_recommended <- npx_br_data_clean |>
dplyr::filter(
.data[["BridgingRecommendation"]] != "NotBridgeable"
)
## Option 2: Analyze non-bridgeable assays separately
# No further preprocessing needed
npx_recommended <- npx_br_data_clean### npx_post_br_clean generated by olink_normalization with format = FALSE
## Option 1: Exclude non-bridgeable assays from both products
npx_recommended <- npx_br_data_clean |>
dplyr::mutate(
NPX_original = .data[["NPX"]]
) |>
dplyr::filter(
.data[["BridgingRecommendation"]] != "Not Bridgeable"
) |>
dplyr::mutate(NPX = dplyr::case_when(
.data[["BridgingRecommendation"]] == "MedianCentering" ~
.data[["MedianCenteredNPX"]],
.data[["BridgingRecommendation"]] == "QuantileSmoothing" ~
.data[["QSNormalizedNPX"]],
.default = .data[["NPX"]]
)
) |>
dplyr::mutate(
OlinkID_HT = .data[["OlinkID"]]
) |>
dplyr::mutate(
OlinkID = paste0(.data[["OlinkID"]], "_", .data[["OlinkID_E3072"]])
)
# Option 2: Analyze non bridgeable assays separately
npx_recommended <- npx_br_data_clean |>
dplyr::mutate(
NPX_original = .data[["NPX"]]
) |>
dplyr::mutate(
NPX = dplyr::case_when(
.data[["BridgingRecommendation"]] == "MedianCentering" ~
.data[["MedianCenteredNPX"]],
.data[["BridgingRecommendation"]] == "QuantileSmoothing" ~
.data[["QSNormalizedNPX"]],
.default = .data[["NPX"]]
)
) |>
dplyr::mutate(
OlinkID_HT = .data[["OlinkID"]]
) |>
dplyr::mutate(
OlinkID = dplyr::if_else(
.data[["BridgingRecommendation"]] != "NotBridgeable",
paste0(.data[["OlinkID"]], "_", .data[["OlinkID_E3072"]]),
# Concatenated OlinkID for bridgeable Assays
dplyr::if_else(.data[["Project"]] == "Explore HT",
# replace with reference project name as set in function
.data[["OlinkID"]],
.data[["OlinkID_E3072"]]
)
)
)We are always happy to help. Email us with any questions:
biostat@olink.com for statistical services and general stats questions
support@olink.com for Olink lab product and technical support
info@olink.com for more information
© 2026 Olink Proteomics AB, part of Thermo Fisher Scientific.
Olink products and services are For Research Use Only. Not for use in diagnostic procedures.
All information in this document is subject to change without notice. This document is not intended to convey any warranties, representations and/or recommendations of any kind, unless such warranties, representations and/or recommendations are explicitly stated.
Olink assumes no liability arising from a prospective reader’s actions based on this document.
OLINK, NPX, PEA, PROXIMITY EXTENSION, INSIGHT and the Olink logotype are trademarks registered, or pending registration, by Olink Proteomics AB. All third-party trademarks are the property of their respective owners.
Olink products and assay methods are covered by several patents and patent applications https://www.olink.com/patents/.